Mit Magzter GOLD unbegrenztes Potenzial nutzen

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur

$149.99
 
$74.99/Jahr

Versuchen GOLD - Frei

Gene editing: Are humans really ready to rewrite the book of life?

Mint New Delhi

|

May 14, 2025

Recent advances in this field are both amazing and scary. This amplifies the dilemmas we confront

- SAMIRAN GHOSH is a technology advisor and podcast host.

When Watson and Crick discovered DNA's double helix in 1953, humanity stumbled upon something miraculous and menacing: the ability to edit genes. Not read them, not mildly tweak them, but rewrite them with a divinity complex. Think of it as opening Microsoft Word and creating your fantasy appearance. Rainbow-coloured eyes? Sure. Sounds amazing? It is. Terrifying? Definitely.

Gene editing is like Prometheus handing humanity the genetic matchstick—except this time, instead of fire, we're toying with the instruction manual of life. It all started innocently enough, back in the 1970s, when scientists like Herbert Boyer and Stanley Cohen created recombinant DNA, enabling direct gene manipulation across barriers of species. The 1980s saw the first genetically modified organisms and transgenic animals, while the 1990s brought the ambitious Human Genome Project.

By 2003, scientists had mapped 92% of humanity's complete genetic blueprint. The pace quickened with the 2012 invention of Crispr-Cas9, the tool that democratized precise genetic modification through its relative simplicity and affordability. In one bold move, we accelerated both progress and ethical concerns.

Crispr tech is precise, cheap and fast. It is already being used to cure genetic diseases. Between 2023-25, the UK and US approved therapies that cured—and not just treated—sickle cell anaemia. Patients who lived with chronic pain and blood transfusions are free of the illness.

WEITERE GESCHICHTEN VON Mint New Delhi

Mint New Delhi

Mint New Delhi

Sebi now trains sights on commodity derivatives

Following clampdown on equity derivatives after studies revealed steep retail losses, the stock market regulator is turning its attention to the commodity derivatives segment (CDS).

time to read

2 mins

November 28, 2025

Mint New Delhi

Mint New Delhi

Refiners, SCI tap Korean giants for local shipyard

Indian Oil, Bharat Petroleum and Hindustan Petroleum are part of the discussions

time to read

4 mins

November 28, 2025

Mint New Delhi

Mint New Delhi

360 One, Steadview, others to invest in Wakefit ahead of IPO

A clutch of firms, including 360 One, Steadview Capital, WhiteOak Capital and Info Edge, is expected to invest in home-furnishings brand Wakefit Innovations Ltd just ahead of its initial public offering (IPO) next month, three people familiar with the matter said.

time to read

3 mins

November 28, 2025

Mint New Delhi

Would you like to be interviewed by an AI bot instead?

I don't think I want to be interviewed by a human again,\" said a 58-year-old chartered accountant who recently had an interview with a multinational company.

time to read

3 mins

November 28, 2025

Mint New Delhi

Mint New Delhi

India, UAE review trade agreement to ease market access

Officials of India and the United Arab Emirates (UAE) met on Thursday to review how the Comprehensive Economic Partnership Agreement (CEPA) is working, and remove frictions that may be impeding trade between the two nations.

time to read

1 mins

November 28, 2025

Mint New Delhi

Mint New Delhi

It's a multi-horse Street race now as Smids muscle in

For years, India’s stock market ran on the shoulders of a few giants. Not anymore.

time to read

3 mins

November 28, 2025

Mint New Delhi

Mint New Delhi

The curious case of LIC's voting on RIL, Adani resolutions

Life Insurance Corp. of India Ltd, or LIC, consistently approved or never opposed resolutions proposed before shareholders of Reliance Industries Ltd (RIL) or any Adani Group company since 1 April 2022, even as it rejected several similar proposals at other large companies, some even part of other conglomerates, a Mint review of about 9,000 voting decisions by the government-run insurer showed.

time to read

8 mins

November 28, 2025

Mint New Delhi

Mint New Delhi

Investors expect AI use to soar. That's not happening

On November 20th American statisticians released the results of a survey. Buried in the data is a trend with implications for trillions of dollars of spending.

time to read

4 mins

November 28, 2025

Mint New Delhi

Mint New Delhi

CANADA'S STARTUP VISA: PUTTING LIVES ON HOLD

Legal uncertainty has left entrepreneurs stuck despite building businesses and putting down roots

time to read

8 mins

November 28, 2025

Mint New Delhi

Gupta pilfered from fraud, Trafigura says

Commodity trader Trafigura's lawyers accused Indian businessman Prateek Gupta on Thursday of siphoning off funds from an alleged $600 million metals fraud to prop up his struggling business empire.

time to read

1 min

November 28, 2025

Listen

Translate

Share

-
+

Change font size